<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Russia</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Russia.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/ru.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Stability of live plague vaccine production: Analysis of potency using Shewhart charts</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-30895-2221-996x-2026-753-d2b7454c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-30895-2221-996x-2026-753-d2b7454c/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that statistical process-control methods were used to evaluate consistency of live plague vaccine potency during production. The supplied evidence does not establish clinical effectiveness, safety outcomes, population protection, or a current public-health threat.</description>
    <category>Plague</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Detection of a Novel Gull-like Clade of Newcastle Disease Virus and H3N8 Avian Influenza Virus in the Arctic Region of Russia (Taimyr Peninsula).</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-v17070955-aef136a7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-v17070955-aef136a7/</guid>
    <pubDate>Mon, 07 Jul 2025 00:00:00 GMT</pubDate>
    <description>The manuscript concentrates on avian reservoir dynamics and evolutionary patterns, explicitly noting that direct human health implications remain unaddressed.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Genomic epidemiology</category>
    <category>Surveillance</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-21-00234-8-5b95152a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-21-00234-8-5b95152a/</guid>
    <pubDate>Mon, 01 Feb 2021 00:00:00 GMT</pubDate>
    <description>This interim analysis provides evidence from a large-scale phase 3 trial supporting the efficacy and tolerability of a two-dose adenovirus-vectored COVID-19 vaccine in adults.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Randomised controlled trial</category>
  </item>
</channel>
</rss>
